does blue cross blue shield cover glp-1 drugs of Michigan won't popular weight-loss does blue cross blue shield
Description
Zuyi Yang, orcid.org/0009-0000-3317-4136
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone
Yes if the drug is not on the formulary or prior authorization is denied, the plan can decline to cover it
It belongs to the same class of medications (GLP-1 RAs) and is used for the treatment of Type 2 Diabetes mellitus as well as weight loss
In contrast, patients with chronic kidney disease or heart failure frequently benefit more from SGLT2 inhibitors
The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism
